Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 16.26% |
| 3 | Financials | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
NBT Bancorp
NBTB
$2.68B
| $2.01M | ﹤0.01% |
46,192
-6,735
| -13% | -$297K |
|
1252
Target Hospitality
TH
$1.78B
| $2M | ﹤0.01% |
131,836
+101,037
| +328% | +$1.36M |
|
1253
Sonoco
SON
$5.69B
| $1.99M | ﹤0.01% |
32,996
-50,445
| -60% | -$3.03M |
|
1254
LCI Industries
LCII
$2.52B
| $1.98M | ﹤0.01% |
21,449
+18,677
| +674% | +$1.83M |
|
1255
Take-Two Interactive
TTWO
$44B
| $1.98M | ﹤0.01% |
19,611
-281
| -1% | -$30.4K |
|
1256
Monarch Casino & Resort
MCRI
$2.22B
| $1.98M | ﹤0.01% |
25,723
+2,094
| +9% | +$158K |
|
1257
e.l.f. Beauty
ELF
$6.22B
| $1.97M | ﹤0.01% |
35,606
+1,480
| +4% | +$72.5K |
|
1258
Morningstar
MORN
$8.06B
| $1.97M | ﹤0.01% |
9,078
-1,705
| -16% | -$389K |
|
1259
NOV
NOV
$7.06B
| $1.96M | ﹤0.01% |
95,522
+67,616
| +242% | +$1.42M |
|
1260
Wolverine World Wide
WWW
$1.7B
| $1.96M | ﹤0.01% |
+179,272
| New | +$2.38M |
|
1261
Enova International
ENVA
$6.13B
| $1.96M | ﹤0.01% |
51,012
+1,755
| +4% | +$64.1K |
|
1262
Employers Holdings
EIG
$879M
| $1.95M | ﹤0.01% |
45,231
-939
| -2% | -$38.7K |
|
1263
Apple Hospitality REIT
APLE
$3.93B
| $1.95M | ﹤0.01% |
124,381
+7,342
| +6% | +$118K |
|
1264
Regency Centers
REG
$14B
| $1.94M | ﹤0.01% |
31,166
+103
| +0.3% | +$6.33K |
|
1265
Inspire Medical Systems
INSP
$1.78B
| $1.94M | ﹤0.01% |
7,697
-3,825
| -33% | -$816K |
|
1266
Gold Fields
GFI
$42.7B
| $1.93M | ﹤0.01% |
186,213
-11,897
| -6% | -$115K |
|
|
EQC
1267
DELISTED
Equity Commonwealth
EQC
| $1.93M | ﹤0.01% |
77,150
+28,047
| +57% | +$717K |
|
1268
Urban Edge Properties
UE
$2.71B
| $1.91M | ﹤0.01% |
136,075
+26,065
| +24% | +$374K |
|
1269
Cytokinetics
CYTK
$10.8B
| $1.91M | ﹤0.01% |
41,624
+812
| +2% | +$34.9K |
|
1270
SITE Centers
SITC
$160M
| $1.89M | ﹤0.01% |
177,712
-52,610
| -23% | -$516K |
|
1271
Newell Brands
NWL
$2.53B
| $1.89M | ﹤0.01% |
144,569
+50,315
| +53% | +$688K |
|
1272
Factset
FDS
$10.7B
| $1.88M | ﹤0.01% |
4,679
-7,261
| -61% | -$3.09M |
|
1273
Carriage Services
CSV
$546M
| $1.88M | ﹤0.01% |
68,140
+38,133
| +127% | +$1.04M |
|
|
BBT
1274
Beacon Financial Corp
BBT
$2.65B
| $1.88M | ﹤0.01% |
62,710
+6,659
| +12% | +$196K |
|
1275
World Kinect Corp
WKC
$1.81B
| $1.87M | ﹤0.01% |
69,033
+28,851
| +72% | +$775K |
|
Similar funds
Cliff Asness's Q4 2022 Portfolio in Review
As of Q4 2022, Cliff Asness held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Cliff Asness's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- Cliff Asness added most to Humana in Q4 2022, an estimated $111M increase.
- Cliff Asness's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- Cliff Asness fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- Cliff Asness's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- Cliff Asness opened 170 new positions and closed 150 in Q4 2022.
- Cliff Asness's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.